A
Closed
Advancing Technologies for Spatiotemporal Omics in Live Tissue
Live-tissue omics technology development
Last Update: April 29, 2026
Funding available
$ 500,000 - $ 1,000,000
Timeline
- Open Date : September 16, 2025
- Closing date : November 13, 2025
Location
Canada
Overview
Supports two-year research projects developing live-tissue technologies for real-time spatial proteomic and metabolomic analysis. Funding is available for Focused Projects up to $500,000 USD and Expanded Projects up to $1,000,000 USD, including eligible activities in immunology and autoimmune disease research.
/100
Opportunity Score
Moderate potential, but conditions must align.
At a glance
Funding available
Financing goals
- Increase performance through digital transformation
- Develop strategic partnerships
- Develop team skills
Eligible Funding
- Maximum amount : 1,000,000 $
- Minimum amount : 500,000 $
- Up to 15% of project cost
Timeline
- Open Date : September 16, 2025
- Closing date : November 13, 2025
Eligible candidates
Eligible Industries
- Professional, scientific and technical services
- Educational services
- Health care and social assistance
Location
- Canada
Legal structures
- All legal structures
Annual revenue
- All revenue ranges
Organisation size
- All organization sizes
Audience
- All groups
Next Steps
1
Determine your project
2
Validate your eligibility
Activities funded
- Development of live-tissue technologies for real-time spatial proteomic and metabolomic profiling.
- Engineering and validation of instrumented tissue systems for immune monitoring.
- Creation of integrated sampling and detection platforms for longitudinal analysis.
- Development of computational tools for real-time spatial mapping and data interpretation.
Documents Needed
- Institutional Approval Form
- Project Proposal
- Budget
- Biosketches for the Coordinating PI and Co-PIs
- Optional Letters of Commitment from Co-PIs
Eligibility
Who is eligible?
- Nonprofit organizations
- Colleges and universities
- Hospitals and laboratories
- State and local government units
- Eligible federal government agencies
Who is not eligible
- For-profit organizations receiving funding
- Meta employees and employees of subsidiary Meta entities
- Employees of Chan Zuckerberg Initiative, LLC
- Employees of Chan Zuckerberg Biohub, Inc.
Eligible expenses
- Personnel costs
- Supplies and equipment
- Travel and meeting-related costs
- Subcontracts and other project costs
- Indirect costs up to 15%
Ineligible Costs and Activities
- Travel expenses to the United States for international grantees
- Indirect costs on capital equipment
- Indirect costs on subcontracts
Eligible geographic areas
- Domestic and foreign organizations
- Applicants from any country, subject to compliance requirements
Processing and Agreement
- Applications are reviewed for scientific merit and eligibility.
- Independent expert review is used in the evaluation process.
- Final decisions are made by CZI and Biohub Network staff with scientific advisors.
- Applicants are notified of decisions in late February 2026, subject to change.
- Selected projects require ongoing progress and financial reporting.
Additional information
- Up to three PIs per application.
- Institutional approval form required.
- Annual progress reports are required.
Contacts
Frequently Asked Questions about the Advancing Technologies for Spatiotemporal Omics in Live Tissue Program
Here are answers to the most common questions about the Advancing Technologies for Spatiotemporal Omics in Live Tissue. This section explains what the program is, how much funding is available, eligibility requirements, application deadlines, and other important details to help you determine if this grant is right for your business.
What is the Advancing Technologies for Spatiotemporal Omics in Live Tissue?
Supports two-year research projects developing live-tissue technologies for real-time spatial proteomic and metabolomic analysis. Funding is available for Focused Projects up to $500,000 USD and Expanded Projects up to $1,000,000 USD, including eligible activities in immunology and autoimmune disease research.
How much funding can be received?
Advancing Technologies for Spatiotemporal Omics in Live Tissue Funds up to 15% of admissible expenses, capped at $1,000,000 per project.
What is the deadline to apply?
The application deadline for this grant program was November 13, 2025.
Who is eligible for the Advancing Technologies for Spatiotemporal Omics in Live Tissue program?
To be eligible for the Advancing Technologies for Spatiotemporal Omics in Live Tissue program, you must:
Nonprofit or institutional applicants
Lead PI tied to host institution
Up to three PIs per application
What expenses are eligible under Advancing Technologies for Spatiotemporal Omics in Live Tissue?
Development of live-tissue technologies for real-time spatial proteomic and metabolomic profiling.
Engineering and validation of instrumented tissue systems for immune monitoring.
Creation of integrated sampling and detection platforms for longitudinal analysis.
Development of computational tools for real-time spatial mapping and data interpretation.
Who can I contact for more information about the Advancing Technologies for Spatiotemporal Omics in Live Tissue?
You can contact Chan Zuckerberg Initiative (CZI) by email at sciencegrants@chanzuckerberg.com.
Where is the Advancing Technologies for Spatiotemporal Omics in Live Tissue available?
The Advancing Technologies for Spatiotemporal Omics in Live Tissue program is available across Canada.